Genomic Expressions & Octagon Therapeutics

Posted on May 11, 2021 by Beacon Angels

At its monthly breakfast meeting on Tuesday, May 11th, 2021, Beacon Angels members entertained the following presenters:  

  • Octagon Therapeutics, which is developing precision immunomodulators for chronic autoimmune diseasethat specifically target immune dysregulation; and
  • Genomic Expressions, which offers OneRNA,® a disease agnostic exponentially scalable RNA analysis platform to detect disease, monitor health and design next-generation cures.

Members reported on companies in due diligence consisting of: 

  • Yarn Corporation; and
  • AOA Diagnostics.

We heard updates on the funding rounds of Cognoptix, GelMEDIX, RevBio and Xeno Biosciences.

Beacon Angels members delivered portfolio company updates.

About Beacon Angels

Angel group, founded in 2006, that invests in early stage start-up companies--New England based only.
This entry was posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings and tagged , , . Bookmark the permalink.